German Pharma Giant Merck to Acquire US-Based SpringWorks Therapeutics for $3.9 Billion
Berlin: German pharmaceutical company Merck announced Monday that it has reached an agreement to acquire US-based SpringWorks Therapeutics for $3.9 billion, a move aimed at strengthening its oncology portfolio and expanding its presence in the United …